| Literature DB >> 22513311 |
Abstract
Although clinical trials often provide "best evidence" comparing the effectiveness of alternative management strategies, such evidence can be limited in duration or in the results reported, causing clinicians and policy analysts to wonder "what if?" Models of the clinical prognosis-often spanning patients' lifetimes (the "long haul")-are perhaps weaker evidence, but can help answer questions about the management of individual patients and place that best evidence into the context of clinical reality.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22513311 PMCID: PMC3711094 DOI: 10.1038/clpt.2012.25
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875